- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
AusCann Announces Packaging Agreement with Aspen Pharmacare
AusCann announced it has chosen Aspen Pharmacare Australia to provide packaging for its medicinal cannabis pharmaceutical products.
On Monday (November 25), AusCann Group Holdings Limited (ASX:AC8) announced it tagged TGA-licensed Aspen Pharmacare Australia to provide packaging for its medicinal cannabis pharmaceutical products.
As quoted in the press release:
The appointment of Aspen derives from AusCann’s careful management of its supply chain and cost base, and aims to de-risk the supply chain in the most cost effective manner, ensure quality compliance, and follows similar partnerships with cultivation & extraction, manufacturing, and controlled distribution service providers. The agreement with Aspen is for an initial three year period that can be extended and will include GMP packaging services for AusCann’s proprietary solid hard shell capsules. These will be manufactured under contract by AusCann’s manufacturing partner, PCI Pharma, and will be packaged by Aspen in consumer ready packs at its Australian facility. This agreement is the result of a detailed financial analysis that indicated a considerable cost benefit for packaging outsourcing with Aspen.
Click here to read the full press release.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Â